Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
NLCQ-1 (NSC 709257): exploiting hypoxia with a weak DNA-intercalating bioreductive drug
That dual approach to energy balance is what researchers believe drives the superior weight loss outcomes
Consistent concentrations simplify dose calculations across different vials
An FDA-cleared sharps container for single-use needle disposal
The organic layer was dried over anhydrous NaSO, filtered, and concentrated under reduced pressure to obtain Compound 4 (yield: 90%)
Unlike its parent molecule, Dihexa exhibits enhanced stability and improved bioavailability, allowing it to readily cross the blood-brain barrier and exert its therapeutic effects
US$ 25.48
US$ 23.70
US$ 21.83
US$ 28.94
US$ 27.94
US$ 24.90
US$ 27.32
US$ 28.83
US$ 20.52
US$ 29.39
US$ 25.48
